No Data
No Data
Stifel Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $60
Express News | Crinetics Pharmaceuticals Inc : JP Morgan Cuts Target Price to $53 From $57
This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Crinetics Pharmaceuticals Analyst Ratings
Stifel Initiates Crinetics(CRNX.US) With Buy Rating, Announces Target Price $60
Insider Sale: Chief Med and Dev Officer of $CRNX Sells 127 Shares